Gastric Emptying Time in Traumatic Injuries

October 14, 2024 updated by: Kantonsspital Winterthur KSW

Gastric Point-of-care Sonography with Focus on Gastric Emptying Time in Patients with Traumatic Injuries. a Prospective Observational Study

The investigators plan to do serial sonographic examinations of the gastric antrum (quantity, quality) to estimate the gastric emptying time and dependant factors after traumatic injurys.

Study Overview

Detailed Description

The investigators plan to do serial sonographic examinations of the gastric antrum (quantity, quality) in patients suffering from a relevant traumatic injury. Patients which are admitted to the emergency department with a corresponding history are considered for inclusion. Patient with life-threatening injuries are excluded. After inclusion, the investigators plan to carry out gastric ultrasound (POCUS) all 2 hours until the operative treatment (maximal 5 examinations). To identify factors which may be correlated with delayed gastric emptying several demographic and patient related factors are collected.

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Winterthur, Switzerland, 8401
        • Recruiting
        • Kantonsspital Winterthur
        • Contact:
        • Contact:
          • Sascha Bättig, resident
        • Contact:
          • Caveh Madjdpour, chief

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

patients admitted to the emergency department with a relevant traumatic injury

Description

Inclusion Criteria:

  • relevant traumatic injury

Exclusion Criteria:

  • life-threatening traumatic injury (immediate treatment is necessary)
  • Underage
  • Known pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sonographic quality/quantity of the gastric antrum
Time Frame: 2 hour
Quality of the gastric content (empty, fluid, solid or mixed fluid/solid) and quantity of the gastric content in ml, measured in 2 hour time intervals
2 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain-scale
Time Frame: 2 hour
Evaluate pain using the VAS Scale 0-10 (Visual Analog Scale)
2 hour
Analgetics
Time Frame: 2 hour
Evaluate need of analgetics
2 hour
Stress, activation of sympathic nerve system
Time Frame: 2 hour
Evaluate stress on a VAS 0-10 (Visual Analog Scale)
2 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2023

Primary Completion (Estimated)

June 30, 2025

Study Completion (Estimated)

September 30, 2025

Study Registration Dates

First Submitted

April 3, 2023

First Submitted That Met QC Criteria

October 14, 2024

First Posted (Actual)

October 16, 2024

Study Record Updates

Last Update Posted (Actual)

October 16, 2024

Last Update Submitted That Met QC Criteria

October 14, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • POCUS 2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia

Clinical Trials on Gastric ultrasound

Subscribe